Moleculin Biotech proposes IPO

Moleculin Biotech Inc., Houston, Texas Business: Cancer Date announced: 2016-02-01 Type: IPO To be raised: Up to $12 million Shares: 2 million Price: $5-$6 Underwriters: Bonwick Capital Partners; Netw...